Skip to content

Smoking Cessation and Reduction With an Electronic Nicotine Delivery Device (ENDD)

Effect of an Electronic Nicotine Delivery Device (ENDD) on Smoking Cessation and Reduction: a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01195597
Enrollment
40
Registered
2010-09-06
Start date
2010-02-28
Completion date
2010-07-31
Last updated
2013-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence, Smoking Cessation

Keywords

electronic cigarette, ENDD, nicotine, smoking cessation, smoking reduction

Brief summary

The study's major aim is to investigate the ability of a commercial Electronic Nicotine Delivery Device (ENDD) to induce long-term smoking reduction/abstinence in smokers unwilling to quit. Secondary aims are to monitor adverse events and measure participants' perception and acceptance of the product. This pilot study will evaluate smoking reduction/abstinence effects, product preferences, and adverse events of a currently marketed device in Italy (Categoria electronic cigarette - ORIGINAL 7.2 mg nicotine cartridges). The primary hypothesis is that the E-Cigarette is a safe device that allows smoking reduction or abstinence in smokers.

Detailed description

Cigarette smoking continues to be a very difficult addiction to break. Therefore, improved approaches to smoking cessation are necessary. The electronic-cigarette (e-Cigarette), a battery-powered electronic nicotine delivery device (ENDD) resembling a cigarette, may help smokers to remain abstinent during their quit attempt or to reduce cigarette consumption. The efficacy of these devices in smoking cessation and/or smoking reduction studies has never been investigated. In this prospective proof-of-concept study we monitored possible modifications in smoking habits of 40 smokers (unwilling to quit) experimenting the 'Categoria' e-Cigarette focusing on smoking reduction and smoking abstinence. Study participants were invited to attend four study visits: at baseline, week-4, week-8, and week-12. Product use, number of cigarettes smoked, and exhaled carbon monoxide (eCO) levels were measured at each visit. Smoking reduction and abstinence rates were calculated. Adverse events and product preferences were also reviewed.

Interventions

DEVICEE-Cigarette 7.2 mg nicotine

Participants were given a free e-Cigarette kit containing two rechargeable batteries, a charger, and two atomizers and instructed on how to charge, activate and use the e-Cigarette. Key troubleshooting were addressed and phone numbers were supplied for both technical and medical assistance. A full 4-weeks supply of 7.2 mg nicotine cartridges (Original cartridges; Arbi Group Srl, Milano, Italy) was also provided and participants were trained on how to load them onto the e-Cigarette's atomizer

Sponsors

Lega Italiana Anti Fumo
CollaboratorOTHER
Arbi Group Srl
CollaboratorINDUSTRY
Universita degli Studi di Catania
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy smokers * unwilling to quit * age 18-60 years * smoking ≥ 15 cig/day for at least 5 years * exhaled CO level of ≥ 15 ppm * FTND ≥ 5

Exclusion criteria

* alcohol and illicit drug use * breastfeeding or pregnancy * major depression or other psychiatric conditions * previous experience with ENDD * recent myocardial infarction * angina pectoris * high blood pressure (BP\>140mm Hg systolic and/or 90mmHg diastolic) * diabetes mellitus * severe allergies * poorly controlled asthma or other airways diseases

Design outcomes

Primary

MeasureTime frameDescription
Sustained 50% Reduction in the Number of Cig/Day at Week-24 From Baseline (Reducers)number of cigarettes/day as assessed at week 24Participants were monitored for up to 24 weeks. This is the number of smokers who sustained 50% reduction in the number of cig/day at week-24 from baseline (reducers).

Secondary

MeasureTime frameDescription
Sustained 80% Reduction in the Number of Cig/Day at Week- 24 From Baseline (Heavy Reducers)number of cigarettes/day as assessed at week 24Participants were monitored for up to 24 weeks. This is the number of partecipants who sustained 80% reduction at week 24

Countries

Italy

Participant flow

Recruitment details

Healthy smokers 18-60 years old, smoking ≥ 15 factorymade cigarettes per day (cig/day) for at least the past 10 years and not currently attempting to quit smoking or wishing to do so in the next 30 days were recruited, Italy. None of the participants reported a history of alcohol and drug use, major depression or other psychiatric conditions.

Participants by arm

ArmCount
ENDD Group
Well characterized group of 40 regular smokers not intending to quit experimenting the E-Cigarette with 7.2 mg nicotine cartridges.
40
Total40

Baseline characteristics

CharacteristicENDD Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
40 Participants
Age Continuous42.9 years
STANDARD_DEVIATION 8.8
Region of Enrollment
Italy
40 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
26 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
22 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

Primary

Sustained 50% Reduction in the Number of Cig/Day at Week-24 From Baseline (Reducers)

Participants were monitored for up to 24 weeks. This is the number of smokers who sustained 50% reduction in the number of cig/day at week-24 from baseline (reducers).

Time frame: number of cigarettes/day as assessed at week 24

Population: Intention to treat (ITT)

ArmMeasureValue (NUMBER)
Smokers Not Willing to QuitSustained 50% Reduction in the Number of Cig/Day at Week-24 From Baseline (Reducers)13 number of participants
Secondary

Sustained 80% Reduction in the Number of Cig/Day at Week- 24 From Baseline (Heavy Reducers)

Participants were monitored for up to 24 weeks. This is the number of partecipants who sustained 80% reduction at week 24

Time frame: number of cigarettes/day as assessed at week 24

Population: Intention to treat (ITT)

ArmMeasureValue (NUMBER)
Smokers Not Willing to QuitSustained 80% Reduction in the Number of Cig/Day at Week- 24 From Baseline (Heavy Reducers)5 number of participants

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026